Y020-8670 Screening compound: 2-methoxy-4-[2-(3-pyridylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-6-yl]phenyl methyl ether

Y020-8670 Screening compound: 2-methoxy-4-[2-(3-pyridylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-6-yl]phenyl methyl ether
Y020-8670 Screening compound: 2-methoxy-4-[2-(3-pyridylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-6-yl]phenyl methyl ether alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8670
2-methoxy-4-[2-(3-pyridylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-6-yl]phenyl methyl ether

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8670

Molecular Formula

C25H25N7O2 (C25 H25 N7 O2)

Compound Name

2-methoxy-4-[2-(3-pyridylmethyl)-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1',2':3,4][1,3,5]triazino[1,2-a][1,3]benzimidazol-6-yl]phenyl methyl ether

IUPAC name

9-(34-dimethoxyphenyl)-4-[(pyridin-3-yl)methyl]-24681017-hexaazatetracyclo[8.7.0.0^{27}.0^{1116}]heptadeca-1(17)7111315-pentaene

SMILES

COc(ccc(C1N=C(NCN(Cc2cnccc2)C2)N2c2nc(cccc3)c3n12)c1)c1OC

InChI

InChI=1S/C25H25N7O2/c1-33-21-10-9-18(12-22(21)34-2)23-29-24-27-15-30(14-17-6-5-11-26-13-17)16-31(24)25-28-19-7-3-4-8-20(19)32(23)25/h3-13,23H,14-16H2,1-2H3,(H,27,29)/t23-/m1/s1

InChI Key

OXDLLRSEAAIRPE-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD09463668

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.387

Distribution Coefficient, logD

3.325

Water Solubility, LogSw

-3.40

Polar Surface Area

63.441

Acid Dissociation Constant (pKa)

18.11

Base Dissociation Constant (pKb)

6.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

Y020-8670 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with Y020-8670 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8670?
Check Price and Availability of Y020-8670, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8670 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8670
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8670
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8670 available by request